Eye Drop Quality Issues: Can the FDA See This One Through?

Lyla R White1, C Michael White1

  • 1School of Pharmacy, University of Connecticut, Storrs, CT, USA.

PubMed
Summary

The Food and Drug Administration (FDA) lacks resources for proactive inspections, especially for lower-priority over-the-counter (OTC) products. Increased funding is crucial to prevent harm from contaminated drugs and ensure public safety.